Skip to main content

Loading market ticker...

Nath Bio-Genes (India) Limited (NSE: NATHBIO) Surges 13%: Is This the Breakout That Could Change the Stock’s Trend?

Nath Bio-Genes (India) Limited (NSE: NATHBIO) Surges 13%: Is This the Breakout That Could Change the Stock’s Trend?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • Nath Bio-Genes (India) Limited shares climbed 13.08% to ₹172.94 on April 13, 2026.
  • The stock surged above its 50-day SMA near ₹145.64 with one of its strongest candles in months.
  • Healthy quarterly profitability and a sharp rise in momentum supported the move.

Overview

Nath Bio-Genes (India) Limited (NSE: NATHBIO) gained 13.08% to ₹172.94 on April 13, 2026, after opening at ₹152.00 and touching an intraday high of ₹183.52. The stock emerged among the top gainers of the session after witnessing a sharp late-session breakout.

The latest move is notable because the stock had been trapped in a broad range for most of 2026 after a prolonged decline through the second half of 2025. The strong close above ₹170.00 suggests that the recent recovery may be strengthening.

Fundamental View

Nath Bio-Genes reported solid standalone earnings for the December 2025 quarter. The company posted total income of ₹6,769.67 lakh, while profit before tax stood at ₹810.35 lakh.

Net profit came in at ₹723.07 lakh and earnings per share stood at ₹3.80. The company’s stable profitability provides support to the recent rise in the stock price.

Technical View

Nath Bio-Genes had been quietly recovering from its March low near ₹128.00, but the latest session completely changed the tone of the chart. The stock opened flat and then exploded higher, creating a long bullish candle that pushed the price to its highest level in several months.

The move carried the stock well above its 50-day Simple Moving Average near ₹145.64 and also lifted it beyond the upper end of its recent consolidation band. The breakout came after several weeks of narrowing price action, which often leads to a stronger directional move once the range is broken.

The 14-day RSI has jumped to 75.86, reflecting very strong momentum after the latest surge. The indicator is now in the overheated zone, which suggests that the stock may remain volatile even if the broader up move continues.

Key Technical Levels

The ₹160.00–150.00 region may now act as an important support band if the stock witnesses some cooling after the sharp rally. On the upside, the next zone to watch is ₹185.00–200.00, where the stock may encounter fresh pressure if the current move extends further.

Source: TradingView

Risk to Watch

  • The RSI has moved into the overheated zone after the sharp rally.
  • The stock has already gained significantly in a short period and may remain volatile.
  • Failure to hold above ₹160.00 could weaken the recent breakout.
  • Any slowdown in momentum could trigger profit booking near higher levels.

Summary

Nath Bio-Genes appears to have broken out of its prolonged consolidation phase after a powerful rally above the 50-day SMA. The move is supported by healthy quarterly earnings and strong momentum. However, the sharp rise has also pushed the RSI into the overheated zone, which may keep the stock volatile in the near term.

FAQs

Why did Nath Bio-Genes share price rise today?

The stock rose after breaking out above its recent trading range and 50-day SMA, supported by stronger momentum and healthy quarterly earnings.

What is the 50-day SMA for Nath Bio-Genes?

The 50-day Simple Moving Average for Nath Bio-Genes is currently near ₹145.64.

How much net profit did Nath Bio-Genes report in December 2025?

Nath Bio-Genes reported a net profit of ₹723.07 lakh in the December 2025 quarter.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.